BOOK A DEMO

Discover How You Can Grow Your Practice with VelacurTM at TSGE 2021

VelacurTM, the first handheld 3D liver health assessment solution, is coming to the 2021 Annual TSGE Conference, September 24 to 26!

If you care for patients with chronic liver disease (including fatty liver disease) or are interested in building your practice, visit our booth for a live VelacurTM demo and to connect with our team.

Developed by Sonic Incytes Medical Corp, VelacurTM is a new, non-invasive liver imaging test with accuracy comparable to MRI.

For more information about VelacurTM or to book a private demo, visit www.velacur.com.

Follow us on LinkedIn, Twitter, and YouTube, and subscribe to our e-newsletter below.

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.